全民药物覆盖与糖尿病患者医疗费用的社会经济差异
该研究利用加拿大安大略省行政健康数据库,分析2004年4月至2014年3月698,113名20-64岁及≥65岁糖尿病成人,按社区社会经济地位(SES)五分位比较医疗费用。结果显示,最低SES组较最高SES组在年轻成人中费用高39%,老年成人仅高9%;调整后非药物费用在年轻成人Q1较Q5每人年高1,569加元。结论认为SES是糖尿病相关医疗费用的预测因素,尤其在缺乏全民药物覆盖的65岁以下人群中更为明显。
要点
- 年轻成人最低SES组(Q1)较最高SES组(Q5)未调整人均年费用高39%(5,954加元 vs 4,270加元)。
- 老年成人最低SES组(Q1)较最高SES组(Q5)未调整人均年费用仅高9%(10,917加元 vs 9,993加元)。
- 调整后非药物费用在年轻成人Q1较Q5每人年高1,569加元,相对费用差异为35.7%。
核心结论
- SES是本研究环境中糖尿病相关医疗费用的预测因素,在65岁以下缺乏全民药物覆盖的成人中更为明显。
- 年轻低SES成人的非药物医疗费用高出三分之一以上,10年期间医疗支出增加超过10亿加元。
研究设计与样本
- 利用行政健康数据库分析2004年4月至2014年3月安大略省698,113名20-64岁及≥65岁糖尿病成人的公共资助医疗支出。
- 采用广义线性模型,按年龄调整年龄、性别、糖尿病病程和合并症后,检验社区SES五分位间总费用和非药物费用的相对与绝对差异。
主要发现
- 未调整人均年费用在最低SES五分位(Q1)与最高(Q5)比较:年轻成人Q1为5,954加元 vs Q5为4,270加元(高39%),老年成人Q1为10,917加元 vs Q5为9,993加元(高9%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether neighborhood socioeconomic status (SES) is a predictor of non-drug-related health care costs among Canadian adults with diabetes and, if so, whether SES disparities in costs are reduced after age 65 years, when universal drug coverage commences as an insurable benefit. RESEARCH DESIGN AND METHODS: Administrative health databases were used to examine publicly funded health care expenditures among 698,113 younger (20-64 years) and older (≥65 years) adults with diabetes in Ontario from April 2004 to March 2014. Generalized linear models were constructed to examine relative and absolute differences in health care costs (total and non-drug-related costs) across neighborhood SES quintiles, by age, with adjustment for differences in age, sex, diabetes duration, and comorbidity. RESULTS: Unadjusted costs per person-year in the lowest SES quintile (Q1) versus the highest (Q5) were 39% higher among younger adults ($5,954 vs. $4,270 [Canadian dollars]) but only 9% higher among older adults ($10,917 vs. $9,993). Adjusted non-drug costs (primarily for hospitalizations and physician visits) were $1,569 per person-year higher among younger adults in Q1 vs. Q5 (modeled relative cost difference: 35.7% higher) and $139.3 million per year among all individuals in Q1. Scenarios in which these excess costs per person-year were decreased by ≥10% or matched the relative difference among seniors suggested a potential for savings in the range of $26.0-$128.2 million per year among all lower-SES adults under age 65 years (Q1-Q4). CONCLUSIONS: SES is a predictor of diabetes-related health care costs in our setting, more so among adults under age 65 years, a group that lacks universal drug coverage under Ontario's health care system. Non-drug-related health care costs were more than one-third higher in younger, lower-SES adults, translating to >$1 billion more in health care expenditures over 10 years.
引用
- Isaranuwatchai W, Fazli GS, Bierman AS, et al. Universal Drug Coverage and Socioeconomic Disparities in Health Care Costs Among Persons With Diabetes. Diabetes Care. 2020. PMID: 32641377. doi:10.2337/dc19-1536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。